Axovant Gene Therapies Ltd.

(NGS:AXGT) Trade

Symbol has changed to a new ticker symbol


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Axovant Gene Therapies Ltd is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis. It currently has three clinical-stage programs which include AXO-Lenti-PD program for Parkinson's disease, AXO-AAV-GM1 program for GM1 gangliosidosis, and AXO-AAV-GM1 program for GM2 gangliosidosis (including Tay-Sachs and Sandhoff diseases).

Contact Information

Main Phone: +44 2039978931
Address: 11-12 St. James's Square
Address 2: Suite 1, 3rd Floor
City / Town: London
Country: GB
Postal Code: SW1Y 4LB

Issuer Information

Exchange: NGS
CEO: Pavan Cheruvu
Employees: 38
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A